PUZHUVETTU (Alopecia areata) in Children - Silvisha usidham (Internal) and Puzhuvettu thylam (External)

Preclinical and Clinical evaluation of Silvisha Usidham (Internal) and Puzhuvettu Thylam (External) for Puzhuvettu (Alopecia areata) in Children.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011311

Enrollment

Registered

2018-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Puzhuvettu (Alopecia areata)

Interventions

Intervention1: Silvisha Usidham Puzhuvettu Thylam : 2-4ml of Silvisha Usidham will be orally twice a day for a period of 45days Puzhuvettu Thylam will be apply externally for 45days Control Intervent

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patchy hair loss in the scalp 2 Non Scarring 3 Scattered long hair within bald area 4 Patient who is willing to be admitted in the hospital or willing to attend OPD when required 5 Willing to sign the informed and consent form

Exclusion criteria

Exclusion criteria: 1 Scarring alopecia 2 Alopecia totalis 3 Alopecia universalis 4 Thyroid disease 5 Atopic dermatitis 6 Vitiligo 7 Pernicious anaemia 8 Down syndrome

Design outcomes

Secondary

Measure	Time frame
Comparing the improvement of clinical symptoms before and after treatmentTimepoint: 45days	—

Primary

Measure	Time frame
It is mainly assessed by SALT ScoreTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr R D Indumathi

National Institute of Siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026